Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...
PNC dropped 20%+, offering a potential value buy. Read here for PNC stock's its strengths in corporate banking, deposit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback